A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation

Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
11/2011
11/24/2011	WO2011145964A2 Method and device for producing an informational medicinal preparation
11/24/2011	WO2010142400A3 Chitosan oligosaccharide-based compositions
11/24/2011	US20110288238 Enhanced transport using membrane disruptive agents
11/23/2011	CN1897978B Assembly of gas-filled microvesicle with active component for contrast imaging
11/23/2011	CN102256622A Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy
11/23/2011	CN102256591A Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
11/23/2011	CN102250102A Alpha(beta)quinoline-oligopolycthylene glycol phthalocyanine zinc and preparation method thereof
11/23/2011	CN102250101A Bis-alpha-quinoline-low molecular polyethylene glycol phthalocyanine zinc and preparation method thereof
11/23/2011	CN102249940A Amphiphilic benzylidene cyclopentanone dye, its synthetic method and application in two-photon photodynamic therapy
11/23/2011	CN102249939A Lipid-water amphiphilic benzylidene cyclopentanone dye and preparation method and application in photodynamic therapy thereof
11/23/2011	CN102247362A Pharmaceutical application of compound and preparation thereof
11/23/2011	CN101591340B 5,10,15,20-tetra-(5-drewamine amyl)-chlorin, preparation and application thereof in field of medicaments and pesticides
11/22/2011	CA2482826C Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
11/17/2011	WO2011143609A1 Formulations of diluted genetic material and methods for making same
11/17/2011	US20110280947 Embolization
11/16/2011	CN102245027A Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth
11/15/2011	CA2410387C Polymerizable compositions and methods of use
11/10/2011	WO2011137514A1 Imageable activatable agent for radiation therapy and method and system for radiation therapy
11/10/2011	US20110275672 Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/09/2011	EP2384312A2 Water clusters, products with water clusters, and methods of producing
11/09/2011	EP1663103B1 Compositions of botanical extracts for cancer therapy
11/03/2011	WO2010143970A3 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
11/02/2011	CN102231991A Active particles for bio-analytical applications and methods for their preparation
11/02/2011	CN101885692B 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof
11/01/2011	CA2461662C Method and tools for oral hygiene
10/2011
10/27/2011	WO2010143971A3 Lipophilic drug carrier
10/26/2011	EP2379109A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature
10/25/2011	CA2531862C Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
10/20/2011	WO2011129348A1 Composition for treatment of cancer which is produced from cancer-tissue-derived cell mass or cancer cell aggregate, and process for production of immunotherapeutic agent and method for evaluation of efficacy of immunotherapy both using the composition
10/19/2011	EP2377574A2 Implant and applicator
10/19/2011	EP2376493A1 Dihydropyrimidopyrimidine derivative
10/19/2011	EP2376459A1 Modified pyrazine derivatives and uses thereof
10/19/2011	EP2376458A1 Modified pyrazine derivatives and uses thereof
10/19/2011	EP1499321B1 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect")
10/19/2011	CN102219768A Perylenequinone compounds and their extraction and separation method and use
10/18/2011	CA2494541C Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/13/2011	WO2011127061A1 Enhancement of radiation therapy by targeted high-z nanoparticles
10/13/2011	WO2011125600A1 Method and device for cell activation
10/13/2011	WO2011124944A1 Light energy-induced stability of biomaterials
10/13/2011	WO2011009903A3 Material system comprising endoperoxide adapting to decomposition, and applications
10/12/2011	EP2374463A1 Composition for improving radiotherapy for cancer
10/12/2011	EP2373312A1 A composition for use on skin and wound
10/12/2011	CN102212090A Water-soluble sugar phthalocyanine fluorescent compound, and preparation method and application thereof
10/11/2011	US8034803 Photodynamic therapy of occult age-related macular degeneration
10/11/2011	US8034792 Insulin-like growth factor binding protein 7 for treatment of cancer
10/11/2011	US8034314 Photoreactive compound specifically binding to calcium binding proteins
10/11/2011	US8033977 Methods of enhancing radiation effects with metal nanoparticles
10/11/2011	CA2587328C New derivatives of porphyrin including chlorine and/or bacteriochlorins and their applications in photodynamic therapy
10/11/2011	CA2536977C Non-polar photosensitizer formulations for photodynamic therapy
10/06/2011	WO2011031915A3 Azulene and azaazulene systems for imaging, monitoring and therapy
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/05/2011	EP2371392A1 Calicheamicin derivative-carrier conjugates
10/05/2011	EP2370115A1 Hydrogel sponges, methods of producing them and uses thereof
09/2011
09/29/2011	WO2011117503A1 Device for delivering calories into human or animal tissue, vessel, or cavity
09/29/2011	WO2010143972A3 Acoustically sensitive drug delivery particles comprising inverted structure forming lipids
09/29/2011	WO2010143969A3 Acoustically sensitive drug delivery particles comprising phosphatidylethanolamine
09/28/2011	EP2368598A1 Photodisinfection devices and methods
09/28/2011	EP2368597A1 Photodisinfection devices and methods
09/28/2011	CN1980661B Cationic bacteriochlorophyll derivatives and uses thereof
09/28/2011	CN102198271A Method for preparing medicament-nanometer calcium phosphate composite system taking fat soluble photosensitizer as framework and application of system in preparation of medicaments for photodynamic therapy
09/27/2011	US8026371 Hydroxamates as therapeutic agents
09/27/2011	CA2531620C Cancer combination therapy comprising azd2171 and zd1839
09/27/2011	CA2467723C Method for treating cervical cancer
09/22/2011	WO2011113140A1 Magnetic apparatus used for drug delivery
09/22/2011	WO2011078695A3 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
09/22/2011	US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
09/21/2011	EP2365829A1 Combination of an oxidant and a photoactivator for the healing of wounds
09/15/2011	US20110223167 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
09/15/2011	CA2701539A1 Magnetic conductive recipient
09/14/2011	EP2364954A1 System and method for electromagnetic treatment of wastewater
09/14/2011	EP2049664B1 Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders
09/14/2011	EP2026765B1 Hyperthermic technologies and therapeutic uses thereof
09/13/2011	US8017736 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/09/2011	CA2791990A1 Radiotherapy combined with hypoxic cell sensitizers
09/07/2011	EP2363133A1 Composition comprising DNA fragments and medical and cosmetic uses thereof
09/07/2011	EP2362901A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents
09/07/2011	CN102176948A Radiofrequency hyperthermia device with target feedback signal modulation
09/07/2011	CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy
09/07/2011	CN102172411A Nano complex particles with targeted MR (magnetic resonance) development and photothermal therapy performance and preparation method thereof
09/06/2011	US8012945 Single chain fragment variable (scFv) antibody or an Fab antibody; screening phage-displayed antibodies for an ability to bind to a radiation-inducible neoantigen present on a cell
09/06/2011	US8012454 Embolization
09/01/2011	WO2011106481A1 Dna dendrimers as thermal ablation devices
09/01/2011	WO2011105963A1 Photosensitizer-containing composition
09/01/2011	US20110213293 Ligands to radiation-induced molecules
09/01/2011	CA2789789A1 Dna dendrimers as thermal ablation devices
08/2011
08/31/2011	EP1079824B1 Triterpene compositions and methods for use thereof
08/31/2011	CN102170866A Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions
08/31/2011	CN102170836A Method and device for marking a medium, and marker usable in such a method
08/31/2011	CN102166182A Nanometer probe and application thereof in tumor diagnosis composition and photodynamic therapy
08/31/2011	CN102166138A Nanosecond laser device capable of improving abrasion resistance and corrosion resistance of tooth
08/31/2011	CN101200469B Separation of regioisomers of metal phthalocyanines
08/30/2011	US8008077 Photochemical internalization for delivery of molecules into the cytosol
08/25/2011	WO2011102407A1 Radiation therapy agent
08/24/2011	EP2359900A2 Method for capturing the changes induced in an initial crystal structure by the action of the acoustic and electromagnetic fields of a biological medium and a device for carrying out said method, method for duplicating the changes in the initial crystal structure in the structure of a duplicate crystal (variants) and a device for carrying out said method (variants), method for exerting an effect on a biological object (variants) and a device for carrying out said method
08/24/2011	EP1883362B1 Apparatus and method to apply substances to tissue
08/24/2011	EP1558616B2 Meso-substituted porphyrins
08/24/2011	EP1531843B1 Method for treating cervical cancer
08/23/2011	US8003129 Enhanced transport using membrane disruptive agents
08/23/2011	CA2484070C Antibacterial compositions comprising metal phthalocyanine analogues
08/18/2011	US20110200695 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue

1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 95